Mark Ahn: Biotech Expert, Entrepreneur, And Educator

Mark J. Ahn Ph.D. is an entrepreneur, biotech specialist, and educator. He has a very diverse educational background. Mark Ahn’s degrees include a BA and MBA from Chaminade University, an MA in Classics from Victoria University, University of Toronto, and a PhD in Business Administration from the University of South Australia. But what really makes Mark Ahn special is his vision and drive. He has founded and co-founded a number of companies and worked in the upper level of management in many others. Dr. Ahn is equally comfortable working with start-ups or established companies.
University of Essex

In his 20 years working in the biotech the list of companies he has been involved with and positions he has held is truly impressive. Mark Ahn was CEO, President, and Director at Galena Biopharma, Inc., CEO, CFO and President of RXi Pharmaceuticals Corporation, Co-Founder of 2 Ignite Fund and Sparkbox, and a principal at Pukana Partners, Ltd. Dr. Ahn founded Hana Biosciences Inc., was CEO, President, and Executive Director of Talon Therapeutics, Inc., and director of TransMolecular, Inc.,
Mesynthes Ltd., Essia Health Inc. and Immusoft Corporation.

Mark Ahn’s extensive experience with such a wide range of companies makes him uniquely qualified to offer advice to people interested in starting biotech companies. Recently he spoke on what it takes to succeed in the industry. He said that while most biotech startups have great promise, excitement, and potentially world-changing ideas and products, smart investors should forge ties, and research alliances, and acquire minority stakes in a number of diverse small companies.

Mark Ahn said for start-ups to succeed they should stick with their plan and don’t try to follow trends because biotech product development cycles can be long and start-ups may need multiple rounds of funding. But if they stick with their business plan they can succeed. Mark Ahn has outlined his thoughts on what it takes for investors in and founders of biotech start-ups need to do to succeed in an article entitled “Biotechnology Innovation: A Legitimacy-Based View” which appeared in the International Journal of Innovation Technology Management

Mark Ahn not only builds companies of his own, he also works as a consultant to biotech companies of every stripe. Plus he works with young people in academic settings as a professor at three different colleges, Victoria University, Carnegie Mellon, and Portland State University. Ahn is the author of over 50 peer reviewed journal articles and books.

You can follow Mark Ahn on Twitter.

Leave a Reply